Long-Term Survivor with Intrathecal and Intravenous Trastuzumab Treatment in Metastatic Breast Cancer

Use of Chemotherapy plus a Monoclonal Antibody against HER2 for Metastatic Breast Cancer That Overexpresses HER2

Dennis J. Slamon, Brian Leyland‐Jones, Steven Shak et al. · New England Journal of Medicine · 2001 · 11.5K citations · Full text

Medicine, Oncology, Pharmacology +10

Prognosis of Women With Metastatic Breast Cancer by <i>HER2</i> Status and Trastuzumab Treatment: An Institutional-Based Review

Shaheenah Dawood, Kristine Broglio, Aman U. Buzdar et al. · Journal of Clinical Oncology · 2009 · 765 citations

Medicine, Oncology, Pharmacology +17

Ratio of trastuzumab levels in serum and cerebrospinal fluid is altered in HER2-positive breast cancer patients with brain metastases and impairment of blood–brain barrier

Hans‐Joachim Stemmler, Manfred Schmitt, Amina Willems et al. · Anti-Cancer Drugs · 2006 · 411 citations

Medicine, Oncology, Pharmacology +17

The relevance of intraventricular chemotherapy for leptomeningeal metastasis in breast cancer: a randomised study

Willem Boogerd, Martin J. van den Bent, Peter J. Koehler et al. · European Journal of Cancer · 2004 · 285 citations · Full text

Medicine, Oncology, Surgery +13

Survival of breast cancer patients with meningeal carcinomatosis

H. Gauthier, M.N. Guilhaume, François‐Clément Bidard et al. · Annals of Oncology · 2010 · 188 citations · Full text

Medicine, Oncology, Surgery +13